Synopsis of recent research by authors named "Rie Nishikino"
- Rie Nishikino's research primarily focuses on the adherence and safety of diabetes medications, specifically DPP-4 inhibitors and SGLT2 inhibitors, within the context of Japanese clinical practice.
- In her 2016 study, she analyzed medication adherence among type 2 diabetes patients using DPP-4 inhibitors, revealing gaps in persistence and discontinuation rates that warrant further investigation.
- Her earlier work in 2015 highlighted the short-term impacts and safety concerns associated with SGLT2 inhibitors, emphasizing the need for careful monitoring of serious adverse events during their initial use in clinical settings.
